CAS: 1080622-86-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CP466722 REF: IN-DA008TF3CAS: 1080622-86-1 | 98% | 49.00 €~207.00 € | Tue 25 Mar 25 |
 | CP-466722 REF: TM-T6261CAS: 1080622-86-1 | 99.14% - 99.85% | 35.00 €~1,074.00 € | Tue 01 Apr 25 |
 | CP-466722 REF: TR-C781395CAS: 1080622-86-1 | - - - | 1,568.00 € | Mon 05 May 25 |
 | 2-(6,7-dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine REF: 3D-FD43368CAS: 1080622-86-1 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA008TF3
| 10mg | 62.00 € | ||
| 25mg | 72.00 € | ||
| 100mg | 140.00 € | ||
| 250mg | 207.00 € |
Estimated delivery in United States, on Tuesday 25 Mar 2025
CP-466722
CAS:1080622-86-1
CP-466722, an effective and reversible ATM inhibitor, does not inhibit ATR and PI3K or PIKK …
Formula:
C17H15N7O2
Purity:
99.14% - 99.85%
Color and Shape:
Solid
Molecular weight:
349.35
Ref: TM-T6261
| 1mg | 35.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 74.00 € | ||
| 10mg | 115.00 € | ||
| 25mg | 183.00 € | ||
| 50mg | 296.00 € | ||
| 100mg | 480.00 € | ||
| 500mg | 1,074.00 € |
Estimated delivery in United States, on Tuesday 1 Apr 2025
CP-466722
Controlled ProductCAS:1080622-86-1
Applications CP466722 is a competetive, reversible inhbitor of Ataxia telangiectasia (A-T) mutated (ATM) kinase References …
Formula:
C17H15N7O2
Color and Shape:
Neat
Molecular weight:
349.347
Ref: TR-C781395
| 10mg | 1,568.00 € |
Estimated delivery in United States, on Monday 5 May 2025
2-(6,7-dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine
CAS:1080622-86-1
2-(6,7-Dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine is an inhibitor drug that is used in the treatment of cancer. It inhibits …
Formula:
C17H15N7O2
Purity:
Min. 95%
Molecular weight:
349.35 g/mol
Ref: 3D-FD43368
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
